Loeffler endocarditis complicated by cardiogenic shock and angioinvasive Fusarium fujikuroi infection: a case report.

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
European Heart Journal: Case Reports Pub Date : 2026-09-12 eCollection Date: 2026-10-01 DOI:10.1093/ehjcr/ytag670
Jack Simmons, Ahmed K Saleh, Preston Nicely, William Morgan, Stephen Clarkson
{"title":"Loeffler endocarditis complicated by cardiogenic shock and angioinvasive <i>Fusarium fujikuroi</i> infection: a case report.","authors":"Jack Simmons, Ahmed K Saleh, Preston Nicely, William Morgan, Stephen Clarkson","doi":"10.1093/ehjcr/ytag670","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Loeffler endocarditis is a form of restrictive cardiomyopathy that affects up to half of patients with hypereosinophilic syndromes. Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at increased risk of mixed cardiogenic and septic shock due to its restrictive ventricular physiology and treatment with immunosuppressive therapy.</p><p><strong>Case summary: </strong>A 64-year-old female with peripheral eosinophilia and heart failure with mildly reduced ejection fraction reported 6 months of fatigue, worsening lower extremity oedema, palpitations, dyspnoea on exertion, and orthopnoea. She was diagnosed with Loeffler endocarditis based on cardiac magnetic resonance imaging and was initiated on high-dose prednisone and rituximab. While undergoing treatment of a subsequent angioinvasive fungal infection, she developed mixed cardiogenic and septic shock requiring inotropic support and broad-spectrum antimicrobials. She was eventually weaned off inotropic support and was continued on long-term posaconazole for the angioinvasive fungal infection.</p><p><strong>Discussion: </strong>Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at an increased risk of mixed cardiogenic and septic shock. Late-stage Loeffler endocarditis predisposes to cardiogenic shock due to restrictive ventricular physiology and thrombi obliterating the ventricular cavities, while immunosuppressive therapy increases risk of opportunistic infections. If immunosuppression is initiated before ventricular fibrosis occurs, progression of Loeffler endocarditis can be halted or reversed.</p>","PeriodicalId":11910,"journal":{"name":"European Heart Journal: Case Reports","volume":"10 10","pages":"ytag670"},"PeriodicalIF":0.7000,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695071/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjcr/ytag670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Loeffler endocarditis is a form of restrictive cardiomyopathy that affects up to half of patients with hypereosinophilic syndromes. Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at increased risk of mixed cardiogenic and septic shock due to its restrictive ventricular physiology and treatment with immunosuppressive therapy.

Case summary: A 64-year-old female with peripheral eosinophilia and heart failure with mildly reduced ejection fraction reported 6 months of fatigue, worsening lower extremity oedema, palpitations, dyspnoea on exertion, and orthopnoea. She was diagnosed with Loeffler endocarditis based on cardiac magnetic resonance imaging and was initiated on high-dose prednisone and rituximab. While undergoing treatment of a subsequent angioinvasive fungal infection, she developed mixed cardiogenic and septic shock requiring inotropic support and broad-spectrum antimicrobials. She was eventually weaned off inotropic support and was continued on long-term posaconazole for the angioinvasive fungal infection.

Discussion: Patients undergoing treatment of Loeffler endocarditis with immunosuppression are at an increased risk of mixed cardiogenic and septic shock. Late-stage Loeffler endocarditis predisposes to cardiogenic shock due to restrictive ventricular physiology and thrombi obliterating the ventricular cavities, while immunosuppressive therapy increases risk of opportunistic infections. If immunosuppression is initiated before ventricular fibrosis occurs, progression of Loeffler endocarditis can be halted or reversed.

吕弗勒心内膜炎并发心源性休克和血管侵袭性藤黑镰刀菌感染1例。
背景:吕弗勒心内膜炎是一种限制性心肌病,影响多达一半的嗜酸性粒细胞增多综合征患者。接受免疫抑制治疗的吕弗勒心内膜炎患者由于其限制性心室生理和免疫抑制治疗,发生心源性和感染性混合休克的风险增加。病例总结:一名64岁女性,外周血嗜酸性粒细胞增多,心力衰竭伴轻度射血分数降低,报告了6个月的疲劳,下肢水肿加重,心悸,用力时呼吸困难和直呼。根据心脏磁共振成像,她被诊断为吕弗勒心内膜炎,并开始使用大剂量强的松和利妥昔单抗。在接受随后的血管侵袭性真菌感染治疗时,她出现心源性和感染性混合休克,需要肌力支持和广谱抗菌药物。她最终停止了肌力支持,并继续长期服用泊沙康唑治疗血管侵袭性真菌感染。讨论:接受免疫抑制治疗的吕弗勒心内膜炎患者发生心源性和感染性混合休克的风险增加。由于限制性心室生理和血栓阻塞心室腔,晚期吕弗勒心内膜炎易发生心源性休克,而免疫抑制治疗增加机会性感染的风险。如果在心室纤维化发生前开始免疫抑制,可阻止或逆转吕弗勒心内膜炎的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Heart Journal: Case Reports
European Heart Journal: Case Reports Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.30
自引率
10.00%
发文量
451
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书